121 related articles for article (PubMed ID: 2046526)
1. In vivo monitoring of changes in 5-fluorouracil metabolism induced by methotrexate measured by 19F NMR spectroscopy.
Koutcher JA; Sawyer RC; Kornblith AB; Stolfi RL; Martin DS; Devitt ML; Cowburn D; Young CW
Magn Reson Med; 1991 May; 19(1):113-23. PubMed ID: 2046526
[TBL] [Abstract][Full Text] [Related]
2. Effect of modulators on 5-fluorouracil metabolite patterns in murine colon carcinoma determined by in vitro 19F nuclear magnetic resonance spectroscopy.
Kamm VJ; Rietjens IM; Vervoort J; Heerschap A; Rosenbusch G; Hofs HP; Wagener DJ
Cancer Res; 1994 Aug; 54(16):4321-6. PubMed ID: 8044779
[TBL] [Abstract][Full Text] [Related]
3. Inhibition by methotrexate of the stable incorporation of 5-fluorouracil into murine bone marrow DNA.
Sawyer RC; Stolfi RL; Martin DS; Balis ME
Biochem Pharmacol; 1989 Jul; 38(14):2305-11. PubMed ID: 2751696
[TBL] [Abstract][Full Text] [Related]
4. Direct 19F NMR spectroscopic observation of 5-fluorouracil metabolism in the isolated perfused mouse liver model.
Cabanac S; Malet-Martino MC; Bon M; Martino R; Nedelec JF; Dimicoli JL
NMR Biomed; 1988 Jun; 1(3):113-20. PubMed ID: 3152774
[TBL] [Abstract][Full Text] [Related]
5. In vivo 19F nuclear magnetic resonance spectroscopy: a potential monitor of 5-fluorouracil pharmacokinetics and metabolism.
Evelhoch JL
Invest New Drugs; 1989 Apr; 7(1):5-12. PubMed ID: 2661482
[TBL] [Abstract][Full Text] [Related]
6. Enhanced 5-fluorouracil cytotoxicity and elevated 5-fluoronucleotides in the rat Walker carcinosarcoma following methotrexate pre-treatment: a 19F-MRS study in vivo.
McSheehy PM; Prior MJ; Griffiths JR
Br J Cancer; 1992 Mar; 65(3):369-75. PubMed ID: 1558790
[TBL] [Abstract][Full Text] [Related]
7. Loss of murine tumor thymidine kinase activity in vivo following 5-fluorouracil (FUra) treatment by incorporation of FUra into RNA.
Nord LD; Martin DS
Biochem Pharmacol; 1991 Nov; 42(12):2369-75. PubMed ID: 1722409
[TBL] [Abstract][Full Text] [Related]
8. Metabolites of 5-fluorouracil in plasma and urine, as monitored by 19F nuclear magnetic resonance spectroscopy, for patients receiving chemotherapy with or without methotrexate pretreatment.
Hull WE; Port RE; Herrmann R; Britsch B; Kunz W
Cancer Res; 1988 Mar; 48(6):1680-8. PubMed ID: 3125967
[TBL] [Abstract][Full Text] [Related]
9. Enhancement of 5-fluorouracil anabolism by methotrexate and trimetrexate in two rat solid tumor models, Walker 256 carcinosarcoma and Novikoff hepatoma, as evaluated by 19F-magnetic resonance spectroscopy.
Katzir I; Shani J; Wolf W; Chatterjee-Parti S; Berman E
Cancer Invest; 2000; 18(1):20-7. PubMed ID: 10701363
[TBL] [Abstract][Full Text] [Related]
10. 5-Fluorouracil metabolite patterns in viable and necrotic tumor areas of murine colon carcinoma determined by 19F NMR spectroscopy.
Kamm YJ; Heerschap A; Rosenbusch G; Rietjens IM; Vervoort J; Wagener DJ
Magn Reson Med; 1996 Sep; 36(3):445-50. PubMed ID: 8875416
[TBL] [Abstract][Full Text] [Related]
11. 5-Fluorouracil metabolism and cytotoxicity after pre-treatment with methotrexate or thymidine in human hypopharynx and colon carcinoma xenografts: a 19F-nuclear magnetic resonance spectroscopy study in vivo.
Tausch-Treml R; Baumgart F; Ziessow D; Köpf-Maier P
Cancer Chemother Pharmacol; 1996; 37(3):259-65. PubMed ID: 8529287
[TBL] [Abstract][Full Text] [Related]
12. In vivo effect of 5-ethynyluracil on 5-fluorouracil metabolism determined by 19F nuclear magnetic resonance spectroscopy.
Adams ER; Leffert JJ; Craig DJ; Spector T; Pizzorno G
Cancer Res; 1999 Jan; 59(1):122-7. PubMed ID: 9892196
[TBL] [Abstract][Full Text] [Related]
13. 19F NMR monitoring of in vivo tumor metabolism after biochemical modulation of 5-fluorouracil by the uridine phosphorylase inhibitor 5-benzylacyclouridine.
Holland SK; Bergman AM; Zhao Y; Adams ER; Pizzorno G
Magn Reson Med; 1997 Dec; 38(6):907-16. PubMed ID: 9402191
[TBL] [Abstract][Full Text] [Related]
14. Locoregional administration of 5-fluoro-2'-deoxyuridine (FdUrd) in Novikoff hepatoma in the rat: effects of dose and infusion time on tumor growth and on FdUrd metabolite levels in tumor tissue as determined by 19F-NMR spectroscopy.
Naser-Hijazi B; Berger MR; Schmähl D; Schlag P; Hull WE
J Cancer Res Clin Oncol; 1991; 117(4):295-304. PubMed ID: 1829730
[TBL] [Abstract][Full Text] [Related]
15. In vivo measurements of intratumoral metabolism, modulation, and pharmacokinetics of 5-fluorouracil, using 19F nuclear magnetic resonance spectroscopy.
el-Tahtawy A; Wolf W
Cancer Res; 1991 Nov; 51(21):5806-12. PubMed ID: 1933851
[TBL] [Abstract][Full Text] [Related]
16. Thymidine-modulated 5-fluorouracil metabolism in liver and RIF-1 tumors studied by 19F magnetic resonance spectroscopy.
Sijens PE; Ng TC
Magn Reson Imaging; 1992; 10(3):385-92. PubMed ID: 1406088
[TBL] [Abstract][Full Text] [Related]
17. Modulation of 5-fluorouracil metabolism and cytotoxicity by antimetabolite pretreatment in human colorectal adenocarcinoma HCT-8.
Benz C; Cadman E
Cancer Res; 1981 Mar; 41(3):994-9. PubMed ID: 7459888
[TBL] [Abstract][Full Text] [Related]
18. Assignment and pH dependence of the 19F-NMR resonances from the fluorouracil anabolites involved in fluoropyrimidine chemotherapy.
Lutz NW; Hull WE
NMR Biomed; 1999 Jun; 12(4):237-48. PubMed ID: 10421915
[TBL] [Abstract][Full Text] [Related]
19. Noninvasive spectroscopic analysis of fluoropyrimidine metabolism in cultured tumor cells.
Keniry M; Benz C; Shafer RH; James TL
Cancer Res; 1986 Apr; 46(4 Pt 1):1754-8. PubMed ID: 3456267
[TBL] [Abstract][Full Text] [Related]
20. Improved therapeutic index with sequential N-phosphonacetyl-L-aspartate plus high-dose methotrexate plus high-dose 5-fluorouracil and appropriate rescue.
Martin DS; Stolfi RL; Sawyer RC; Spiegelman S; Young CW
Cancer Res; 1983 Oct; 43(10):4653-61. PubMed ID: 6603903
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
